Study Reveals Stigma is Preventing Prostate Cancer Screening and Treatment in Ghana

January 25, 2013 by  
Filed under Prostate Cancer News

Ghana is one the many countries in West Africa that have had hard time dealing with infectious diseases and increased death rates.

However, cancer disease like prostate cancer might well become an epidemic in the region if current trend on how it perceived is not addressed.

A study carried out by a Ghanaian Oncologist and other researchers in the United States has identified stigma as one of the many problems leading to lack of screening and poor treatment for late -stage prostate cancer in the region.

Details of the research have been highlighted below:

Infectious diseases in Ghana tend to capture the most attention, but a quiet crisis may soon take over as the country’s most threatening epidemic: cancer.

This is Kosj Yamoah, M.D., Ph.D., of Thomas Jefferson University and Hospital.(credit:Eurekalert.com)

A new study published in January in the journal BMC Cancer, led by Kosj Yamoah, M.D., Ph.D., a resident in the Department of Radiation Oncology at Thomas Jefferson University and Hospital, takes aim at the issue by investigating prostate cancer diagnoses and treatment delivery in black men living in the West African region, in order to devise research strategies to help improve health outcomes.

Overall, many men are diagnosed at a later stage, with more than half opting out of treatment, they found. The researchers point to stigmas about cancer as a root of the problem.

“Cancer could eclipse infectious diseases as an epidemic if more awareness and intervention doesn’t come about,” said Dr. Yamoah, who grew up in Ghana until age 20, when he came to the United States. “Cancer can be very hush-hush because of cultural and financial issues and social stigmas associated with the disease. We need to bring awareness and address the needs of the population and barriers to care.”

“Cancer is still perceived as a death sentence,” he added. “People are scared to go to their doctor to find out if they have it, let alone to follow through with treatment.”

In a retrospective analysis of 379 patients referred for treatment at the National Center for Radiotherapy and Nuclear Medicine at the Korle Bu Teaching Hospital (KBTH) from 2003 to 2009, the team found that 33 percent were diagnosed with metastatic disease and 70 percent had a prostate-specific antigen (PSA) score four times higher than men in the United States or Europe at time of diagnosis.

PSA screening rates in Ghana are low, the authors explain, and many men opt out of radiation therapy and other therapies after diagnosis. Out of the 251 patients eligible for radiation therapy, only 141 patients actually received external beam radiation therapy.

Among patients with at least two years of follow up after external beam radiation therapy, three- and five-year PSA-failure free survival was 73.8 percent and 65.1 percent respectively. In the U.S., those percentages are 90 percent and 85 percent, respectively.

Reasons recognized by KBTH clinicians for patients declining radiation therapy included: the prohibitive cost of treatment, fear of radiation, and a state of denial based on their perception of disease originating solely from spiritual causes rather than biologic processes.

The data, which to date provides the largest source of published information on outcomes for prostate cancer treatment in the West African region, is a call to action, according to the authors.

The research team plans to develop treatment regimens tailored to the needs of Ghanaian men, which may differ from guidelines currently utilized in the Unites States and Europe in order to better address the disease burden and improve mortality rates in Ghana. That could mean more frequent PSA screening.

“There is controversy in the United States with PSA testing, but in a country like Ghana, there may be a role for PSA screening, even infrequent screening, because of all the late stage cancers we are finding,” said Dr. Yamoah.

The team has established collaboration between two institutions with the hope of improving prostate cancer treatment and plan to start more clinical trials to develop novel, shorter course treatments for locally-advanced prostate cancer.

“Based on these results, our group has proposed a plan for future research aimed at identifying an appropriate role for PSA screening in this population, developing radiation therapy treatment schedules that better fulfill the needs of Ghanaian prostate cancer patients, and contributing to understanding genetic factors associated with prostate cancer risk and treatment response,” the authors write.

Sarah E. Hegarty, a statistical analyst in the Department Pharmacology & Experimental Therapeutics at Jefferson, and Terry Hyslop, Ph.D., also of the Department Pharmacology & Experimental Therapeutics at Jefferson, were also part of the study. Source.

Finally, important factors on why there are poor responses to prostate cancer in Ghana have been identified. These factors need to be addressed so as to solve the prostate cancer problem in the region.

Black men are more prone to prostate cancer than men of other race even as there are many factors that could make a man become a patient.

If the issue of stigma is controlled, then it would open up more awareness for screening and treatment of patients in the region.

Below Are Other Related Articles Among 1,000+ Prostate Cancer Articles On
This HUGE 4+ Year Old Prostate Cancer Victory Authority Website:

(95% of these 1,000+ Prostate Cancer Articles on this website
are written by our Expert In -house Writers, after lots of research.
The remaining 5% are news articles and videos from relevant sources!)


  1. Latest Study Reveals Compares the Cost Benefits and Effectiveness of Various Prostate Cancer Treatments
  2. Prostate Cancer Screening – The PSA Test and DRE Screening
  3. Study Reveals High Fiber Diet Reduces Progression of Prostate Cancer
  4. Prostate Cancer Screening For Middle-Age Men Recommended By a New Study
  5. Why Prostate Cancer Screening Programs Are Important
  6. Targeted Prostate Cancer Screening Can Save Men from Unnecessary Cost and Treatment
  7. Diagnosis And Treatment Health Prostate Cancer – Early Screening
  8. Research Reveals No Difference Between Proton Radiotherapy(PRT) and Intensity-Modulated Radiotherapy (IMRT) in Toxicity After Prostate Cancer Treatment
  9. Preventing Prostrate Cancer with Lots of Sex
  10. Preventing Prostrate Cancer – 5 SUPER Tips That will Help
  11. Preventing Prostate Cancer – One more Good case for Tomatoes
  12. PSA Prostate Cancer Screening – Who Needs It?
  13. Radiation Therapy Candidates for New Investigational Study On Prostate Cancer Treatment
  14. No Prostate Cancer PSA Screening Recommended By U.S. Health Panel – Follow Up – More Condemnation From Experts – Video
  15. The Importance Of The PSA Test In Prostate Cancer Screening

Speak Your Mind

Tell us what you're thinking... !

s